No-reflow phenomenon myocardial contrast echocardiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Jennifer Giuseffi, M.D.; David M. Leder, M.D.; Ayokunle Olubaniyi, M.B,B.S [2]

Overview

This is the gold standard technique for investigating no-reflow phenomenon. This involves the use of intravascular contrast agents that contain tracers. This modality can be used to assess microvascular perfusion. It has the advantage of defining the extent of myocardium affected and also producing a good prognostic value which correllates with the TMPG.^[1]

References

↑ Ito, H.; Maruyama, A.; Iwakura, K.; Takiuchi, S.; Masuyama, T.; Hori, M.; Higashino, Y.; Fujii, K.; Minamino, T. (1996). “Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction”. Circulation. 93 (2): 223–8. PMID 8548892. Unknown parameter |month= ignored (help)

Template:WikiDoc Sources

[Ito-1996-1] Ito, H.; Maruyama, A.; Iwakura, K.; Takiuchi, S.; Masuyama, T.; Hori, M.; Higashino, Y.; Fujii, K.; Minamino, T. (1996). “Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction”. Circulation. 93 (2): 223–8. PMID 8548892. Unknown parameter |month= ignored (help)

[1]

No-reflow phenomenon myocardial contrast echocardiography

Overview

References

Looking for the patient version?